A higher-dose version of semaglutide, called Wegovy, is FDA-approved for chronic weight management
Long-standing tendinopathy, established labral problems, and degenerative changes show improvement in a smaller percentage of users
The findings differ between the groups and experimental conditions though
Brand-level negotiations vary by budget silo, with Ozempic reimbursed under diabetes spend and Wegovy under obesity or preventive care, granting the innovator flexibility to shift promotional focus
By month 3, I was back to full sessions. Months 3-6: The Sweet Spot Whats happening: Side effects resolve substantially
While neither drug is officially approved by the FDA for weight loss, they are frequently used off-label for this purpose